News 2018

ATRO Medical obtains permission to start clinical study with knee meniscus prosthesis

Date: 10/12/2018

10 December 2018, Nijmegen, The Netherlands – ATRO Medical BV has obtained permission from the Healthcare and Youth Inspection to implant the meniscal prosthesis Trammpolin® in eighteen patients. ATRO Medical BV does this together with Radboudumc, the Maastricht UMC+ and the Sint Maartenskliniek. (more…)

Cristal Therapeutics appoints Dr. Axel Mescheder as CEO and CMO

Date: 02/11/2018

2 November 2018, Maastricht, The Netherlands – Cristal Therapeutics has appointed Dr. Axel Mescheder to the role of Chief Executive Officer (CEO) with immediate effect. He will also serve as Chief Medical Officer (CMO). (more…)

Cristal Therapeutics initiates phase 2 clinical trial with CriPec docetaxel in ovarian cancer

Date: 25/10/2018

25 October 2018 , Maastricht, The Netherlands – Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient has been dosed in its Phase 2 clinical trial of lead nanomedicine candidate CPC634 for patients with platinum-resistant ovarian cancer. (more…)

MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018

Date: 15/09/2018

15 September 2018, Utrecht, The Netherlands – MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018. (more…)

Interview with Danae Delbeke, CEO of Indigo

Date: 10/09/2018

10 September 2018, Gent, Belgium – The high-quality Belgian business journal De Tijd this weekend featured an interview with Danae Delbeke, (more…)

Thuja invests in Salvia BioElectronics

Date: 22/05/2018

22 May 2018, Eindhoven – Salvia BioElectronics B.V. announced today that it secured € 1.3 million in seed funding to develop a minimally invasive bioelectronics solution for people suffering from chronic neurological disease. (more…)

Thuja Capital exits NightBalance to Philips

Date: 08/05/2018

8 May, 2018, Utrecht, The Netherlands – Thuja Capital announced it has sold its shareholding in NightBalance B.V. (The Hague, Netherlands) to Royal Philips (NYSE: PHG, AEX: PHIA). (more…)

NutriLeads wins EUR 2.5M Horizon2020 SME funding

Date: 29/03/2018

March 29, Wageningen, The Netherlands. NutriLeads, a Dutch Health Ingredients company announces that its NUTRI-NEED project has been selected for €2.5 million funding under the European Innovation Council SME Instrument (phase 2). (more…)

Hemics in the news

Date: 21/02/2018

21 February 2018 – A nice overview was published on recent developments within the rheumatoid arthritis diagnostics space. Please find the article here. (English language).